- Investing Ideas
- Swedish Pharmaceuticals & Biotech Most Popular Stocks
Swedish Pharmaceuticals & Biotech Most Popular Stocks
Results
91
Most Popular Stocks on the market
91 companies
Swedish Orphan Biovitrum
Market Cap: SEK 165.7b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 479.00
7D
3.5%
1Y
67.5%
Camurus
Market Cap: SEK 34.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 573.00
7D
3.3%
1Y
-15.1%
BioArctic
Market Cap: SEK 29.3b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 330.60
7D
2.0%
1Y
78.0%
AddLife
Market Cap: SEK 20.7b
Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.
ALIF B
SEK 170.10
7D
-0.5%
1Y
-8.4%
Bonesupport Holding
Market Cap: SEK 14.8b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEX
SEK 224.60
7D
7.4%
1Y
-21.6%
Vitrolife
Market Cap: SEK 12.3b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 91.10
7D
2.5%
1Y
-36.8%
BioGaia
Market Cap: SEK 12.1b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 120.00
7D
1.7%
1Y
13.1%
MedCap
Market Cap: SEK 8.2b
A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout.
MCAP
SEK 545.00
7D
6.0%
1Y
10.9%
Swedencare
Market Cap: SEK 4.1b
Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.
SECARE
SEK 25.80
7D
3.4%
1Y
-43.4%
Vicore Pharma Holding
Market Cap: SEK 3.8b
A clinical-stage pharmaceutical company, develops therapies for the treatment of respiratory diseases in Sweden.
VICO
SEK 13.44
7D
9.8%
1Y
76.1%
Hansa Biopharma
Market Cap: SEK 3.5b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
HNSA
SEK 34.88
7D
1.4%
1Y
28.9%
Egetis Therapeutics
Market Cap: SEK 2.8b
A pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally.
EGTX
SEK 5.75
7D
-1.2%
1Y
22.2%
Flerie
Market Cap: SEK 2.0b
A venture capital firm specializing in early-stage investments.
FLERIE
SEK 20.40
7D
2.5%
1Y
-50.3%
Saniona
Market Cap: SEK 1.8b
A clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, Denmark, and the United Kingdom.
SANION
SEK 13.31
7D
2.9%
1Y
34.9%
BioInvent International
Market Cap: SEK 1.7b
A clinical-stage company, discovers and develops immuno-modulatory antibodies for cancer therapy in Sweden, Europe, the United States, and internationally.
BINV
SEK 25.55
7D
6.2%
1Y
-29.1%
Cereno Scientific
Market Cap: SEK 1.6b
A clinical stage biotechnology company, develops therapeutics to treat cardiovascular and pulmonary diseases in Sweden.
CRNO B
SEK 5.13
7D
4.7%
1Y
-45.7%
Curasight
Market Cap: DKK 942.9m
Develops therapeutic and diagnostic solutions for the treatment of cancer.
CURAS
DKK 19.50
7D
-8.5%
1Y
736.9%
Genovis AB (publ.)
Market Cap: SEK 1.4b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 20.45
7D
5.6%
1Y
-30.7%
BICO Group
Market Cap: SEK 1.2b
Provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally.
BICO
SEK 16.46
7D
0.7%
1Y
-53.8%
Medivir
Market Cap: SEK 1.1b
A pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationally.
MVIR
SEK 1.82
7D
7.2%
1Y
19.3%
AlzeCure Pharma
Market Cap: SEK 1.1b
Operates as a pharmaceutical company that develops small-molecule drug therapies for the treatment of severe diseases and conditions that affect the central nervous system.
ALZCUR
SEK 7.66
7D
96.9%
1Y
157.9%
Devyser Diagnostics
Market Cap: SEK 1.0b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 60.70
7D
-29.3%
1Y
-53.3%
SynAct Pharma
Market Cap: SEK 1.0b
A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.
SYNACT
SEK 18.92
7D
2.8%
1Y
-5.4%
Infant Bacterial Therapeutics
Market Cap: SEK 943.0m
Operates as a clinical stage pharmaceutical company develops and markets drugs to prevent serious neonatal diseases affecting premature infants in Sweden.
IBT B
SEK 70.00
7D
4.5%
1Y
46.3%
Orexo
Market Cap: SEK 846.8m
A pharmaceutical company, provides advance treatments for severe diseases and life-saving rescue medications in the United States, European Union, the United Kingdom, and internationally.
ORX
SEK 24.25
7D
-0.6%
1Y
20.9%
Hamlet BioPharma
Market Cap: SEK 746.3m
Engages in the development of drugs for the treatment and prevention of cancer in Sweden.
HAMLET B
SEK 4.20
7D
14.3%
1Y
1.4%
Xspray Pharma
Market Cap: SEK 727.4m
A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.
XSPRAY
SEK 15.34
7D
2.1%
1Y
-67.9%
Dicot Pharma
Market Cap: SEK 707.6m
Engages in the development of pharmaceutical products in Sweden.
DICOT
SEK 0.20
7D
2.5%
1Y
-60.8%
Oncopeptides
Market Cap: SEK 664.9m
A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.
ONCO
SEK 1.68
7D
3.9%
1Y
-3.3%
FluoGuide
Market Cap: SEK 663.8m
A clinical stage biotechnology company, develops drugs for precision cancer surgery in Denmark.
FLUO
SEK 40.60
7D
-4.7%
1Y
2.0%
Enzymatica
Market Cap: SEK 568.0m
A life science company, develops and sells medical devices for infectious diseases.
ENZY
SEK 2.34
7D
-6.8%
1Y
-18.2%
Cantargia
Market Cap: SEK 543.5m
A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.
CANTA
SEK 2.19
7D
0.8%
1Y
67.9%
Cessatech
Market Cap: DKK 362.2m
A pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark.
CESSA
DKK 19.50
7D
-4.9%
1Y
69.9%
Cinclus Pharma Holding
Market Cap: SEK 520.3m
A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.
CINPHA
SEK 11.18
7D
2.0%
1Y
-29.0%
Corline Biomedical
Market Cap: SEK 463.9m
Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications in Sweden.
CLBIO
SEK 17.75
7D
-2.2%
1Y
38.1%
Intervacc
Market Cap: SEK 453.3m
Develops novel veterinary vaccines for animals in Sweden.
IVACC
SEK 1.33
7D
2.3%
1Y
42.7%